67
Participants
Start Date
January 6, 2023
Primary Completion Date
August 31, 2025
Study Completion Date
September 30, 2028
Encaleret
Administered as film-coated tablet for oral use
Standard of Care
Calcium supplements and/or active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)
Royal North Shore Hospital, Saint Leonards
Royal Brisbane and Women's Hospital, Herston
Aarhus University Hospital, Aarhus
Columbia University Irving Medical Center, New York
The Children's Hospital of Philadelphia, Philadelphia
IRCCS Ospedale San Raffaele, Milan
NIH, Bethesda
Physicians East, Greenville
Ohio State University Medical Center, Columbus
Indiana University Health University Hospital, Indianapolis
Mayo Clinic - Rochester, Rochester
University Hospital of Pisa, Pisa
Hôpital Edouard Herriot - HCL, Lyon
Houston Methodist Hospital, Houston
Children's Hospital Colorado, Aurora
CHU Bicetre, Le Kremlin-Bicêtre
UCSF Benioff Children's Hospital, Oakland, Oakland
Massachusetts General Hospital, Boston
Bone Research & Education Centre, Oakville
Vseobecna fakultni nemocnice v Praze, New Town
Fondazione Policlinico Universitario Campus Bio-Medico, Roma
The University of Tokyo Hospital, Tokyo
Eramus MC, Rotterdam
Freeman Hospital, Newcastle upon Tyne
Norfolk and Norwich University Hospital, Norwich
Calcilytix Therapeutics, Inc., a BridgeBio company
INDUSTRY